Inj, etoposide, 1 mg
Products billed under this code include Etopophos, Etoposide.
Payment limit per 1 MG, by effective quarter, 4Q26 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J9187
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Etopophos | H2 Pharma LLC | 61269-0410-20 | 100 | $9.40 |
| Etoposide | Hikma Pharmaceuticals USA Inc. | 00143-9376-01 | 100 | $9.40 |
| Etoposide | Hikma Pharmaceuticals USA Inc. | 00143-9510-01 | 100 | $9.40 |
| Etoposide | Hikma Pharmaceuticals USA Inc. | 00143-9511-01 | 500 | $47.00 |
| Etoposide | Hikma Pharmaceuticals USA Inc. | 00143-9512-01 | 1000 | $94.00 |
| Etoposide | Accord Healthcare Inc | 16729-0114-08 | 500 | $47.00 |
| Etoposide | Accord Healthcare Inc | 16729-0114-11 | 1000 | $94.00 |
| Etoposide | Accord Healthcare Inc | 16729-0114-31 | 100 | $9.40 |
| Etoposide | FreseniUS Kabi USA, LLC | 63323-0104-05 | 100 | $9.40 |
| Etoposide | FreseniUS Kabi USA, LLC | 63323-0104-06 | 100 | $9.40 |
Show all 20 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Etoposide | FreseniUS Kabi USA, LLC | 63323-0104-25 | 500 | $47.00 |
| Etoposide | FreseniUS Kabi USA, LLC | 63323-0104-50 | 1000 | $94.00 |
| Etoposide | BluePoint Laboratories | 68001-0265-25 | 100 | $9.40 |
| Etoposide | BluePoint Laboratories | 68001-0265-26 | 500 | $47.00 |
| Etoposide | BluePoint Laboratories | 68001-0265-27 | 1000 | $94.00 |
| Etoposide | Bluepoint Laboratories | 68001-0682-26 | 500 | $47.00 |
| Etoposide | Bluepoint Laboratories | 68001-0683-27 | 1000 | $94.00 |
| Etoposide | Meitheal Pharmaceuticals Inc. | 71288-0175-05 | 100 | $9.40 |
| Etoposide | Meitheal Pharmaceuticals Inc. | 71288-0176-25 | 500 | $47.00 |
| Etoposide | Meitheal Pharmaceuticals Inc. | 71288-0177-50 | 1000 | $94.00 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.094 | – | 1 MG | Inj, etoposide, 1 mg | v1, posted September 17, 2026 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026